Clinical trial
Ranolazine in ALS: Safety, and Effect on Cramps, Function and Quality of Life.
NCT06527222 is registered in ClinicalTrials.gov with Swathy Chandrashekhar, MBBS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ranolazine in ALS: Safety, and Effect on Cramps, Function and Quality of Life.
- Lead sponsor
- Swathy Chandrashekhar, MBBS
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- April 29, 2025
- Completion date
- July 31, 2028
- Enrollment
- 72 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.